SCHEMBL7122495

SCHEMBL7122495

FC1(F)OC(F)(F)c2ccccc21

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16404479 0.82 PDK2 (0.30) PDK2
SCHEMBL6924471 0.78 SIGMAR1 (0.43)
SCHEMBL28618972 0.75 PDK2 (0.36) PDK2
SCHEMBL19454302 0.73 PDK2 (0.33) PDK2
SCHEMBL2665687 0.73 KIF11 (0.41)
SCHEMBL29575429 0.73 KIF11 (0.41)
SCHEMBL14803820 0.69 PDK2 (0.38) PDK2
SCHEMBL19454304 0.69 CYP1A2 (0.35) PDK2
SCHEMBL15614862 0.69 AHR (0.34) PDK2
SCHEMBL10260726 0.69 PDK2 (0.35) PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0015577-B1 PROCESS FOR PRODUCING 1,1,3,3-TETRAFLUORO-1,3-DIHYDRO-ISOBENZOFURAN NIHON NOHYAKU CO., LTD. (JP) 1982-02-03 EP claimed
US-4283344-A Process for producing 1,1,3,3-tetrafluoro-1,3-dihydro-isobenzofuran NIHON NOHYAKU CO., LTD. (JP) 1981-08-11 US claimed
EP-0015577-A1 Process for producing 1,1,3,3-tetrafluoro-1,3-dihydro-isobenzofuran NIHON NOHYAKU CO., LTD. (JP) 1980-09-17 EP claimed
JP-55129243-A None JP disclosed
JP-55129242-A None JP disclosed
JP-55129278-A None JP disclosed
US-11917901-B2 Metal complexes UDC IRELAND LIMITED (IE) 2024-02-27 US disclosed
US-11917901-B2 Metal complexes UDC IRELAND LIMITED (IE) 2024-02-27 US disclosed
US-11005050-B2 Metal complexes MERCK PATENT GMBH (DE) 2021-05-11 US disclosed
EP-3424936-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2021-04-07 EP disclosed
US-20200216605-A1 MATERIALS FOR ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2020-07-09 US disclosed
US-4283344-A Process for producing 1,1,3,3-tetrafluoro-1,3-dihydro-isobenzofuran NIHON NOHYAKU CO., LTD. (JP) 1981-08-11 US disclosed
US-4283344-A Process for producing 1,1,3,3-tetrafluoro-1,3-dihydro-isobenzofuran NIHON NOHYAKU CO., LTD. (JP) 1981-08-11 US disclosed
EP-0018481-A1 Process for producing alpha, alpha, alpha-trifluoro-o-toluic fluoride NIHON NOHYAKU CO., LTD. (JP) 1980-11-12 EP disclosed
JP-S55129242-A PREPARATION OF ALPHA,ALPHA,ALPHA-TRIFLUORO-O-TOLUOYL FLUORIDE NIPPON NOHYAKU CO LTD 1980-10-06 JP disclosed
JP-S55129243-A PREPARATION OF ALPHA,ALPHA,ALPHA-TRIFLUORO-O-TOLUOYL FLUORIDE NIPPON NOHYAKU CO LTD 1980-10-06 JP disclosed
JP-S55129278-A PREPARATION OF 1,1,3,3-TETRAFLUORO-1,3-DIHYDRO ISOBENZOFURAN NIPPON NOHYAKU CO LTD 1980-10-06 JP disclosed
EP-0015577-A1 Process for producing 1,1,3,3-tetrafluoro-1,3-dihydro-isobenzofuran NIHON NOHYAKU CO., LTD. (JP) 1980-09-17 EP disclosed
EP-0015577-A1 Process for producing 1,1,3,3-tetrafluoro-1,3-dihydro-isobenzofuran NIHON NOHYAKU CO., LTD. (JP) 1980-09-17 EP disclosed
EP-0015577-A1 Process for producing 1,1,3,3-tetrafluoro-1,3-dihydro-isobenzofuran NIHON NOHYAKU CO., LTD. (JP) 1980-09-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11005050-B2 Metal complexes SOD1, AP1M1, AP3M1 PDK2 2330/4885
US-11917901-B2 Metal complexes MCOLN2, MCOLN1, AP1M1 PDK2 3019/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.